bpc 157 human clinical trials randomized double blind The Peptide Craze Cytoprotection as a Unifying Strategy
Description
Brizic, I

Avoiding these will save you time, money, and frustration

The trial tested oral AOD-9604 at multiple dose levels over 12 weeks

100-250 mcg/da o 1.000 mcg das alternos, 1-2 sem, luego, 250-1.000 mcg/mes hasta remisin, o bien: 1.000 mcg/da (1 sem), 1.000 mcg/sem (4-8 sem), 1.000 mcg/mes
